Stock market today: S&P 500 nears record, Dow, Nasdaq jump as Trump announces reciprocal tariffs, delays implementation
Stocks rallied on Thursday as investors digested fresh inflation data and new tariff announcements from President Trump.
Bridging Technical Innovation And Market Success: A Business Development Guide For Deep Tech
For tech startups, the path from innovation to market success often presents a critical challenge: transforming deep ...
How the Target boycott is causing a beef between Black-owned businesses and consumers
Some Black consumers accused Black business owners of selling out the very racial community that contributed to their success ...
Is The EV 'Moving Target' Beginning To Stabilize?
The "moving target" becomes a little more stable when there are reliable metrics to guide action. If we can project who is ...
Stock market today: Nasdaq leads Dow, S&P 500 higher as latest Trump tariff plan takes shape
Stocks rallied on Thursday as investors digested fresh inflation data and new tariff announcements from President Trump.
Jito (JTO) price forecast: mapping path for potential 50% surge after falling wedge breakout
Jito’s price will likely surge toward the $3.50 target, where buyers could book profits. Meanwhile, breaching this ...
Target Boycott Fuels Tension Between Black Shoppers and Black-Owned Brands
Some Black consumers may be breaking up with Target this February.
Two key steps the UK could take on fiscal pressures and growth
The writer is a research associate at the Financial Markets Group, London School of Economics There is much speculation that ...
Daily Sabah10d
ÅžimÅŸek confident inflation will fall, says understands market doubts
Treasury and Finance Minister Mehmet Şimşek on Tuesday reiterated that the Turkish government’s primary goal is to reduce ...
1 Top Vanguard Fund That Could Be the Best Value Investment Right Now
Within the fund, investors not only get good value, but also plenty of diversification; the Vanguard ETF holds more than 330 ...
CNN on MSN11d
Target was one of the most outspoken supporters of DEI. It’s changed its tune
Target was one of corporate America’s most forceful supporters of diversity and inclusion initiatives and vowed to support ...
Recursion: CDK7 Inhibitor Differentiation Is Initially Paying Off
Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.